水飛薊素 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "水飛薊素" in Chinese language version.

refsWebsite

Global rank Chinese rank

11doi.org

2^nd place

23^rd place

10nih.gov

4^th place

5^th place

5web.archive.org

1^st place

1altmedrev.com

low place

1informapharmascience.com

low place

1elsevier.com

610^th place

388^th place

1archive.today

14^th place

18^th place

1adisonline.com

low place

1cancerresearchuk.org

8,489^th place

8,041^st place

1rotta.com

low place

adisonline.com

Fraschini F, Demartini G, Esposti D. Pharmacology of Silymarin. Clinical Drug Investigation. 2002, 22 (1): 51–65. doi:10.2165/00044011-200222010-00007. （原始内容存档于2013年1月16日）.

altmedrev.com

Kidd P, Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos) (PDF). Alternative Medicine Review. 2005, 10 (3): 193–203 [2010-12-14]. PMID 16164374. （原始内容存档 (PDF)于2017-08-09）.

archive.today

Fraschini F, Demartini G, Esposti D. Pharmacology of Silymarin. Clinical Drug Investigation. 2002, 22 (1): 51–65. doi:10.2165/00044011-200222010-00007. （原始内容存档于2013年1月16日）.

cancerresearchuk.org

Milk thistle and liver cancer. Cancer Research UK. 2015-03-08 [March 2015]. （原始内容存档于2017-02-15）.

doi.org

Barzaghi N, Crema F, Gatti G, Pifferi G, Perucca E. Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet. 1990, 15: 333–8. PMID 2088770. doi:10.1007/bf03190223.
Voinovich D, Perissutti B, Grassi M, Passerini N, Bigotto A. Solid state mechanochemical activation of Silybum marianum dry extract with betacyclodextrins: Characterization and bioavailability of the coground systems. Journal of Pharmaceutical Sciences. 2009, 98 (11): 4119–29. PMID 19226635. doi:10.1002/jps.21704.
Kosina P, Kren V, Gebhardt R, Grambal F, Ulrichová J, Walterová D. Antioxidant properties of silybin glycosides. Phytotherapy Research : PTR. 2002,. 16 Suppl 1: S33–9. PMID 11933137. doi:10.1002/ptr.796.
Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metabolism Reviews. 2004, 36 (1): 57–104. PMID 15072439. doi:10.1081/DMR-120028427. （原始内容存档于2016-03-03）.
Wu JW, Lin LC, Tsai TH. Drug-drug interactions of silymarin on the perspective of pharmacokinetics. Journal of Ethnopharmacology. 2009, 121 (2): 185–93 [2010-12-14]. PMID 19041708. doi:10.1016/j.jep.2008.10.036. （原始内容存档于2020-07-22）.
Thomas W. Flaig; Daniel L. Gustafson; Lih-Jen Su; Joseph A. Zirrolli; Frances Crighton; Gail S. Harrison; A. Scott Pierson; Rajesh Agarwal; L. Michael Glodé. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Investigational New Drugs. 2007, 25 (2): 139–146. doi:10.1007/s10637-006-9019-2.
Fraschini F, Demartini G, Esposti D. Pharmacology of Silymarin. Clinical Drug Investigation. 2002, 22 (1): 51–65. doi:10.2165/00044011-200222010-00007. （原始内容存档于2013年1月16日）.
Rambaldi A, Jacobs BP, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. The Cochrane Database of Systematic Reviews. 2007, (4): CD003620. PMID 17943794. doi:10.1002/14651858.CD003620.pub3.
Bosch-Barrera J, Menendez JA. Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy. Cancer Treat. Rev. (Review). 2015, 41 (6): 540–6. PMID 25944486. doi:10.1016/j.ctrv.2015.04.008.
Singh, Rana P.; Agarwal, Rajesh. Cosmeceuticals and silibinin. Clinics in Dermatology. September 2009, 27 (5): 479–484. PMC 2767273 . PMID 19695480. doi:10.1016/j.clindermatol.2009.05.012.
Tůmová L, Tůma J, Megušar K, Doleža M. Substituted Pyrazinecarboxamides as Abiotic Elicitors of Flavolignan Production in Silybum marianum (L.) Gaertn Cultures in Vitro. Molecules. 2010, 15 (1): 331–340. doi:10.3390/molecules15010331.

elsevier.com

linkinghub.elsevier.com

Wu JW, Lin LC, Tsai TH. Drug-drug interactions of silymarin on the perspective of pharmacokinetics. Journal of Ethnopharmacology. 2009, 121 (2): 185–93 [2010-12-14]. PMID 19041708. doi:10.1016/j.jep.2008.10.036. （原始内容存档于2020-07-22）.

informapharmascience.com

Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metabolism Reviews. 2004, 36 (1): 57–104. PMID 15072439. doi:10.1081/DMR-120028427. （原始内容存档于2016-03-03）.

nih.gov

ncbi.nlm.nih.gov

Barzaghi N, Crema F, Gatti G, Pifferi G, Perucca E. Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet. 1990, 15: 333–8. PMID 2088770. doi:10.1007/bf03190223.
Kidd P, Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos) (PDF). Alternative Medicine Review. 2005, 10 (3): 193–203 [2010-12-14]. PMID 16164374. （原始内容存档 (PDF)于2017-08-09）.
Voinovich D, Perissutti B, Grassi M, Passerini N, Bigotto A. Solid state mechanochemical activation of Silybum marianum dry extract with betacyclodextrins: Characterization and bioavailability of the coground systems. Journal of Pharmaceutical Sciences. 2009, 98 (11): 4119–29. PMID 19226635. doi:10.1002/jps.21704.
Kosina P, Kren V, Gebhardt R, Grambal F, Ulrichová J, Walterová D. Antioxidant properties of silybin glycosides. Phytotherapy Research : PTR. 2002,. 16 Suppl 1: S33–9. PMID 11933137. doi:10.1002/ptr.796.
Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metabolism Reviews. 2004, 36 (1): 57–104. PMID 15072439. doi:10.1081/DMR-120028427. （原始内容存档于2016-03-03）.
Wu JW, Lin LC, Tsai TH. Drug-drug interactions of silymarin on the perspective of pharmacokinetics. Journal of Ethnopharmacology. 2009, 121 (2): 185–93 [2010-12-14]. PMID 19041708. doi:10.1016/j.jep.2008.10.036. （原始内容存档于2020-07-22）.
Hahn G, Lehmann HD, Kürten M, Uebel H, Vogel G. On the pharmacology and toxicology of silymarin, an antihepatotoxic active principle from Silybum marianum (L.) gaertn. Arzneimittelforschung. 1968, 18 (6): 698–704. PMID 5755807.
Rambaldi A, Jacobs BP, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. The Cochrane Database of Systematic Reviews. 2007, (4): CD003620. PMID 17943794. doi:10.1002/14651858.CD003620.pub3.
Bosch-Barrera J, Menendez JA. Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy. Cancer Treat. Rev. (Review). 2015, 41 (6): 540–6. PMID 25944486. doi:10.1016/j.ctrv.2015.04.008.
Singh, Rana P.; Agarwal, Rajesh. Cosmeceuticals and silibinin. Clinics in Dermatology. September 2009, 27 (5): 479–484. PMC 2767273 . PMID 19695480. doi:10.1016/j.clindermatol.2009.05.012.

rotta.com

Rottapharm|Madaus. Media Communications Legalon® （页面存档备份，存于互联网档案馆）. Retrieved March 6 2017.

web.archive.org

Kidd P, Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos) (PDF). Alternative Medicine Review. 2005, 10 (3): 193–203 [2010-12-14]. PMID 16164374. （原始内容存档 (PDF)于2017-08-09）.
Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metabolism Reviews. 2004, 36 (1): 57–104. PMID 15072439. doi:10.1081/DMR-120028427. （原始内容存档于2016-03-03）.
Wu JW, Lin LC, Tsai TH. Drug-drug interactions of silymarin on the perspective of pharmacokinetics. Journal of Ethnopharmacology. 2009, 121 (2): 185–93 [2010-12-14]. PMID 19041708. doi:10.1016/j.jep.2008.10.036. （原始内容存档于2020-07-22）.
Milk thistle and liver cancer. Cancer Research UK. 2015-03-08 [March 2015]. （原始内容存档于2017-02-15）.
Rottapharm|Madaus. Media Communications Legalon® （页面存档备份，存于互联网档案馆）. Retrieved March 6 2017.